Stockreport

Myriad Genetics, Inc.'s (NASDAQ:MYGN) Intrinsic Value Is Potentially 97% Above Its Share Price [Yahoo! Finance]

Myriad Genetics, Inc.  (MYGN) 
Last myriad genetics, inc. earnings: 2/6 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: myriad.com/news-center/investor-information
PDF Current share price of US$13.65 suggests Myriad Genetics is potentially 49% undervalued The US$22.53 analyst price target for MYGN is 16% less than our estimate of fa [Read more]